查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1236116

肺氣腫治療全球市場規模研究與預測，按藥物類型（支氣管擴張劑.類固醇.其他）.分銷渠道（在線供應商.藥店/零售藥房.醫院藥房）.區域分析，2022-2029 年

Global Emphysema Treatment Market Size study & Forecast, by Medication Type (Bronchodilators, Steroids, Others) By Distribution Channel (Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球肺氣腫治療市場預計約為 44.7471 億美元，在 2022-2029 年預測期內以超過 5% 的健康增長率增長。

肺氣腫是一種呼吸系統疾病。 在這種疾病中，肺部稱為肺泡的小氣囊會拉伸或破裂，從而損壞肺泡並導致其失去彈性。 結果，呼吸變得困難。 由於吸煙率增加和慢性阻塞性肺病患病率增加等因素，肺氣腫治療市場正在擴大。

根據 Statista 的數據，過去 100 年來，煙草製品的消費量不斷增加，中國生產約 213 萬噸煙草，成為世界上最大的煙草生產國。 2019年，全球有769萬人死於吸煙。 推動該領域發展的另一個關鍵因素是慢性阻塞性肺病的日益流行。 據 Statista 稱，慢性阻塞性肺病是全球第三大死因。 2019年，全球約有889萬人死於缺血性心髒病。 心髒病最大的可改變風險因素是吸煙.不健康的飲食.超重和缺乏鍛煉。 然而，用於肺氣腫治療的藥物的副作用將阻礙整個 2022-2029 年預測期內的市場增長。

全球肺氣腫治療市場研究考慮的主要區域是亞太地區.北美.歐洲.拉丁美洲和世界其他地區。 由於肺氣腫患病率高和醫療基礎設施支出增加，北美在收入中占主導地位。 根據 Statista 的數據，預計 2023 年北美醫療保健領域的收入將達到 207.7 億美元，2023 年至 2027 年的年增長率為 12.25%。 由於市場上對製造高質量肺氣腫藥物的投資增加等因素，預計亞太地區在預測期內將顯著增長。

近期市場趨勢

  • 2021 年 6 月，Tevas 宣布 PERFOROMIST（富馬酸福莫特羅吸入溶液，20mcg/2ML）在美國上市，用於治療慢性阻塞性肺疾病 (COPD) 患者的支氣管收縮，包括慢性支氣管炎和肺氣腫。
  • 2022 年 7 月，Mylan Pharmaceuticals 獲得主題專家委員會 (SEC) 的批准，該委員會隸屬於中央藥品標準控制組織 (CDSCO)，用於治療慢性阻塞性肺疾病 (COPD)。我們已收到繼續進行 Levefenacin Inhalation 175mcg/3ml 的 3 期臨床試驗。

全球市場報告範圍

  • 歷史數據：2019-2020-2021
  • 估算基準年：2021 年
  • 預測期：2022-2029
  • 報告範圍：收入預測.公司排名.競爭格局.增長因素.趨勢
  • 按地區劃分：北美.歐洲.亞太地區.拉丁美洲.世界其他地區
  • 定制範圍：免費報告定制（最多 8 個工作小時）。 對國家.地區和細分範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年按地區分列的肺氣腫治療市場
    • 2019-2029 年按藥物類型劃分的肺氣腫治療市場
    • 肺氣腫治療市場，按分銷渠道，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球肺氣腫治療市場定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第 3 章肺氣腫治療的全球市場動態

  • 肺氣腫治療市場影響分析（2019-2029）
    • 市場驅動力
      • 吸煙頻率增加
      • 慢性阻塞性肺病的患病率增加
    • 市場挑戰
      • 用於治療肺氣腫的藥物的副作用
    • 市場機會
      • 對增強型醫療保健服務的需求不斷增長

第 4 章全球肺氣腫治療市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 最佳投資機會
  • 關鍵成功策略

第 5 章風險評估 COVID-19 影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球肺氣腫治療市場：按藥物類型分類

  • 市場概況
  • 全球肺氣腫治療市場：按藥物類型.性能潛力分析
  • 2019-2029 年全球肺氣腫治療市場按藥物類型的估計和預測
  • 肺氣腫治療市場.細分市場分析
    • 支氣管擴張劑
    • 類固醇
    • 其他

第 7 章全球肺氣腫治療市場：按分銷渠道

  • 市場概況
  • 全球肺氣腫治療市場：按分銷渠道進行的性能潛力分析
  • 2019-2029 年肺氣腫治療全球市場估計和預測（按分銷渠道）
  • 肺氣腫治療市場.細分市場分析
    • 在線提供商
    • 藥店和配藥店
    • 醫院藥房

第 8 章全球肺氣腫治療市場：區域分析

  • 肺氣腫治療市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年按藥物類型估算和預測
      • 2019-2029 年各分銷渠道的估計和預測
    • 加拿大
  • 歐洲肺氣腫治療市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區肺氣腫治療市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲肺氣腫治療市場概況
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 輝瑞公司
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概覽
      • 近期趨勢
    • Teva pharmaceuticals
    • Orion corporation
    • GlaxoSmithKline plc
    • Hikma Pharmaceuticals plc
    • Verona Pharma
    • Novartis AG
    • AstraZeneca
    • Boehringer Ingelheim International GmbH
    • Mylan Pharmaceuticals

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Emphysema Treatment Market is valued approximately USD 4,474.71 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2022-2029. Emphysema Treatment is respiratory diseases. In these conditions, lungs tiny air sac called alveoli stretch out of shape and ruptured as a result these rupture alveoli become damaged and lose its elasticity. As a result, its make difficulty in breathing. The Emphysema Treatment market is expanding because of factors such as increasing Incidence of Cigarette Smoking and increasing prevalence of chronic obstructive pulmonary disease.

According to the Statista consumption of tobacco products rose over the past century, Furthermore, China was the biggest tobacco producer worldwide with an amount of some 2.13 million metric tons of tobacco produced. In addition, annual number of deaths from smoking reached 7.69 million worldwide in 2019. Another important component driving space is the increasing prevalence of chronic obstructive pulmonary disease. As per Statista, COPD is the third leading cause of death globally. In addition, in 2019, around 8.89 million people worldwide died from ischemic heart disease. The biggest modifiable risk factors for heart disease include smoking, unhealthy diet, being overweight, and a lack of exercise. However, side effects of the drug used in Emphysema Treatment stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Emphysema Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the space in terms of revenue, owing to the high incidences of emphysema and rise in spending in healthcare infrastructure. According to Statista, revenue of North America in the Health Care segment is projected to reach US$20.77bn in 2023 and projected an annual growth rate of 12.25% in between 2023 to 2027.Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising investments in manufacturing of high-quality emphysema drugs in the market space.

Major market players included in this report are:

  • Pfizer, Inc
  • Teva pharmaceuticals
  • Orion corporation
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals plc
  • Verona Pharma
  • Novartis AG
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Mylan Pharmaceuticals

Recent Developments in the Market:

  • In June 2021 Tevas Launch PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, used in treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema., within the United States.
  • In July 2022 Mylan Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to conduct Phase III Clinical Trial of Revefenacin inhalation solution 175 mcg/3ml to treat chronic obstructive pulmonary disease (COPD).

Global Emphysema Treatment Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Medication Type, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Medication Type:

  • Bronchodilators
  • Steroids
  • Others

By Distribution Channel:

  • Online Providers
  • Drug Stores and Retail Pharmacies
  • Hospital Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Emphysema Treatment Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Emphysema Treatment Market, by Medication Type, 2019-2029 (USD Million)
    • 1.2.3. Emphysema Treatment Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Emphysema Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Emphysema Treatment Market Dynamics

  • 3.1. Emphysema Treatment Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing Incidence of Cigarette Smoking
      • 3.1.1.2. Increasing prevalence of chronic obstructive pulmonary disease
    • 3.1.2. Market Challenges
      • 3.1.2.1. Side effects of the drug used in emphysema treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising demand for enhanced healthcare services

Chapter 4. Global Emphysema Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Emphysema Treatment Market, by Medication Type

  • 6.1. Market Snapshot
  • 6.2. Global Emphysema Treatment Market by Medication Type, Performance - Potential Analysis
  • 6.3. Global Emphysema Treatment Market Estimates & Forecasts by Medication Type 2019-2029 (USD Million)
  • 6.4. Emphysema Treatment Market, Sub Segment Analysis
    • 6.4.1. Bronchodilators
    • 6.4.2. Steroids
    • 6.4.3. Others

Chapter 7. Global Emphysema Treatment Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Emphysema Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Emphysema Treatment Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 7.4. Emphysema Treatment Market, Sub Segment Analysis
    • 7.4.1. Online Providers
    • 7.4.2. Drug Stores and Retail Pharmacies
    • 7.4.3. Hospital Pharmacies

Chapter 8. Global Emphysema Treatment Market, Regional Analysis

  • 8.1. Emphysema Treatment Market, Regional Market Snapshot
  • 8.2. North America Emphysema Treatment Market
    • 8.2.1. U.S. Emphysema Treatment Market
      • 8.2.1.1. Medication Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Emphysema Treatment Market
  • 8.3. Europe Emphysema Treatment Market Snapshot
    • 8.3.1. U.K. Emphysema Treatment Market
    • 8.3.2. Germany Emphysema Treatment Market
    • 8.3.3. France Emphysema Treatment Market
    • 8.3.4. Spain Emphysema Treatment Market
    • 8.3.5. Italy Emphysema Treatment Market
    • 8.3.6. Rest of Europe Emphysema Treatment Market
  • 8.4. Asia-Pacific Emphysema Treatment Market Snapshot
    • 8.4.1. China Emphysema Treatment Market
    • 8.4.2. India Emphysema Treatment Market
    • 8.4.3. Japan Emphysema Treatment Market
    • 8.4.4. Australia Emphysema Treatment Market
    • 8.4.5. South Korea Emphysema Treatment Market
    • 8.4.6. Rest of Asia Pacific Emphysema Treatment Market
  • 8.5. Latin America Emphysema Treatment Market Snapshot
    • 8.5.1. Brazil Emphysema Treatment Market
    • 8.5.2. Mexico Emphysema Treatment Market
  • 8.6. Rest of The World Emphysema Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Pfizer, Inc
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Teva pharmaceuticals
    • 9.2.3. Orion corporation
    • 9.2.4. GlaxoSmithKline plc
    • 9.2.5. Hikma Pharmaceuticals plc
    • 9.2.6. Verona Pharma
    • 9.2.7. Novartis AG
    • 9.2.8. AstraZeneca
    • 9.2.9. Boehringer Ingelheim International GmbH
    • 9.2.10. Mylan Pharmaceuticals

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Emphysema Treatment Market, report scope
  • TABLE 2. Global Emphysema Treatment Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Emphysema Treatment Market estimates & forecasts by Medication Type 2019-2029 (USD Million)
  • TABLE 4. Global Emphysema Treatment Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 5. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 6. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Emphysema Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Emphysema Treatment Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. U.S. Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 17. U.S. Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. Canada Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 19. Canada Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. UK Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 22. UK Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. Germany Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 25. Germany Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. France Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 28. France Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. Italy Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 31. Italy Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Spain Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 34. Spain Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. RoE Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 37. RoE Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. China Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 40. China Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. India Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 43. India Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. Japan Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 46. Japan Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. South Korea Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 49. South Korea Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. Australia Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 52. Australia Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. RoAPAC Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. Brazil Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 58. Brazil Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Mexico Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 61. Mexico Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. RoLA Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 64. RoLA Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. Row Emphysema Treatment Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 67. Row Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Emphysema Treatment Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. List of secondary sources, used in the study of global Emphysema Treatment Market
  • TABLE 70. List of primary sources, used in the study of global Emphysema Treatment Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Emphysema Treatment Market, research methodology
  • FIG 2. Global Emphysema Treatment Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Emphysema Treatment Market, key trends 2021
  • FIG 5. Global Emphysema Treatment Market, growth prospects 2022-2029
  • FIG 6. Global Emphysema Treatment Market, porters 5 force model
  • FIG 7. Global Emphysema Treatment Market, pest analysis
  • FIG 8. Global Emphysema Treatment Market, value chain analysis
  • FIG 9. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Emphysema Treatment Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Emphysema Treatment Market, regional snapshot 2019 & 2029
  • FIG 15. North America Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Emphysema Treatment Market 2019 & 2029 (USD Million)
  • FIG 19. Global Emphysema Treatment Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable